Prevalence and causes of low vision and blindness in a Japanese adult population : The tajimi study

To determine the prevalence and causes of low vision and blindness in a Japanese adult population. Population-based cross-sectional study. Randomly selected residents (n = 3870) of Tajimi City, Japan, who were 40 years of age or older. Of the 3021 study participants (78.1% of 3870 eligible persons),...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ophthalmology (Rochester, Minn.) Minn.), 2006-08, Vol.113 (8), p.1354-1362
Hauptverfasser: IWASE, Aiko, ARAIE, Makoto, TOMIDOKORO, Atsuo, YAMAMOTO, Tetsuya, SHIMIZU, Hiroyuki, KITAZAWA, Yoshiaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To determine the prevalence and causes of low vision and blindness in a Japanese adult population. Population-based cross-sectional study. Randomly selected residents (n = 3870) of Tajimi City, Japan, who were 40 years of age or older. Of the 3021 study participants (78.1% of 3870 eligible persons), 2977 (76.9%) underwent a complete ophthalmologic examination including measurement of the best-corrected visual acuity (BCVA) with full subjective refraction using a Landolt ring chart at 5 m. Age- and gender-specific prevalence rates of low vision and blindness were estimated and causes were identified. Low vision and blindness were defined as BCVA in the better eye worse than 20/60 to a lower limit of 20/400 and worse than 20/400, respectively (World Health Organization [WHO] criteria) and worse than 20/40 but better than 20/200 and 20/200 or worse, respectively (United States criteria). The overall prevalence of blindness according to the WHO or U.S. criteria was 0.14% (n = 4; 95% confidence interval [CI], 0.06-0.32). The primary causes were optic atrophy, myopic macular degeneration, retinitis pigmentosa, and uveitis. The overall prevalence of low vision according to the WHO criteria was 0.39% (95% CI, 0.18%-0.60%) and according to the U.S. criteria was 0.98% (95% CI, 0.66%-1.30%), which was significantly greater in women and in the older half of the participants than in the younger half (P = 0.0079 and
ISSN:0161-6420
1549-4713
DOI:10.1016/j.ophtha.2006.04.022